Literature DB >> 16847771

Depression and multiple sclerosis: Review of a lethal combination.

Mitchell T Wallin1, Jeffrey A Wilken, Aaron P Turner, Rhonda M Williams, Robert Kane.   

Abstract

Depression is the most frequent psychiatric disorder in multiple sclerosis (MS) patients. The etiology of depression is multifactorial and likely associated with psychosocial stress, focal demyelinating lesions, and immune dysfunction. Proper diagnosis and severity assessment are critical prior to initiation of therapy. Patients with suicidal ideation should be referred for immediate psychiatric consultation and be closely monitored. While more therapeutic trials for depression in MS are needed, MS patients have been shown to respond to current antidepressant medications and psychotherapy. Unfortunately, patients with MS and major depression or suicidal thoughts are often underassessed and therefore not diagnosed. Unlike other aspects of MS, depression is treatable. Early intervention in depression can prevent declines in quality of life and even death from suicide. This article reviews the unique features, assessment, and treatment of depression in MS. MS care providers should vigilantly assess depression and suicide risk in their patients.

Entities:  

Mesh:

Year:  2006        PMID: 16847771     DOI: 10.1682/jrrd.2004.09.0117

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  25 in total

1.  Clinical management of multiple sclerosis through home telehealth monitoring: results of a pilot project.

Authors:  Aaron P Turner; Mitchell T Wallin; Alicia Sloan; Heidi Maloni; Robert Kane; Lore Martz; Jodie K Haselkorn
Journal:  Int J MS Care       Date:  2013

2.  Relationship between disease-modifying therapy and depression in multiple sclerosis.

Authors:  Stephen S Kirzinger; Jason Jones; Angela Siegwald; Andrew Bryce Crush
Journal:  Int J MS Care       Date:  2013

3.  Depression levels and interferon treatment in people with multiple sclerosis.

Authors:  Sonya Kim; Frederick W Foley; Mary Ann Picone; June Halper; Vance Zemon
Journal:  Int J MS Care       Date:  2012

4.  Ready or not: planning for health declines in couples with advanced multiple sclerosis.

Authors:  Hannah Chen; Barbara Habermann
Journal:  J Neurosci Nurs       Date:  2013-02       Impact factor: 1.230

5.  Heterogeneous depression trajectories in multiple sclerosis patients.

Authors:  Douglas D Gunzler; Nathan Morris; Adam Perzynski; Daniel Ontaneda; Farren Briggs; Deborah Miller; Robert A Bermel
Journal:  Mult Scler Relat Disord       Date:  2016-08-05       Impact factor: 4.339

6.  Walgreens connected care: impact of managed therapy on adherence to medications used to treat multiple sclerosis and related comorbid conditions.

Authors:  Janeen DuChane; Bobby Clark; Francis Staskon; Rick Miller; Kathleen Love; Ian Duncan
Journal:  Int J MS Care       Date:  2015 Mar-Apr

7.  Factors that influence adherence with disease-modifying therapy in MS.

Authors:  Katherine Treadaway; Gary Cutter; Amber Salter; Sharon Lynch; James Simsarian; John Corboy; Douglas Jeffery; Bruce Cohen; Ken Mankowski; Joseph Guarnaccia; Lawrence Schaeffer; Roy Kanter; David Brandes; Charles Kaufman; David Duncan; Ellen Marder; Arthur Allen; John Harney; Joanna Cooper; Douglas Woo; Olaf Stüve; Michael Racke; Elliot M Frohman
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

Review 8.  Suicide prevention in neurology patients: evidence to guide practice.

Authors:  DeJasna S Lewis; Kathryn Hoehn Anderson; Johanna Feuchtinger
Journal:  J Neurosci Nurs       Date:  2014-08       Impact factor: 1.230

9.  Routine depression screening in an MS clinic and its association with provider treatment recommendations and related treatment outcome.

Authors:  L M Stepleman; L M Penwell-Waines; M Rollock; R S Casillas; T Brands; J Campbell; B Ange; J L Waller
Journal:  J Clin Psychol Med Settings       Date:  2014-12

Review 10.  Is multiple sclerosis a mitochondrial disease?

Authors:  Peizhong Mao; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.